Profile | GDS5420 / 214525_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 248.37 | 56 |
GSM1296119 | B_lesional_pre-dose | 220.54 | 54 |
GSM1296076 | C_lesional_pre-dose | 181.35 | 52 |
GSM1296092 | D_lesional_pre-dose | 183.9 | 53 |
GSM1296103 | E_lesional_pre-dose | 223.66 | 54 |
GSM1296078 | F_lesional_pre-dose | 120.62 | 46 |
GSM1296107 | G_lesional_pre-dose | 196.87 | 51 |
GSM1296109 | H_lesional_pre-dose | 162.09 | 48 |
GSM1296080 | I_lesional_pre-dose | 264.26 | 58 |
GSM1296090 | J_lesional_pre-dose | 213.13 | 55 |
GSM1296074 | K_lesional_pre-dose | 166.7 | 52 |
GSM1296111 | L_lesional_pre-dose | 187.36 | 50 |
GSM1296099 | M_lesional_pre-dose | 198.16 | 52 |
GSM1296086 | O_lesional_pre-dose | 272.59 | 59 |
GSM1296117 | P_lesional_pre-dose | 118.99 | 42 |
GSM1296113 | Q_lesional_pre-dose | 194.43 | 50 |
GSM1296096 | R_lesional_pre-dose | 181.08 | 51 |
GSM1296105 | S_lesional_pre-dose | 299.43 | 58 |
GSM1296098 | T_lesional_pre-dose | 213.93 | 53 |
GSM1296101 | U_lesional_pre-dose | 283.26 | 58 |
GSM1296121 | V_lesional_pre-dose | 237.68 | 55 |
GSM1296088 | W_lesional_pre-dose | 153.76 | 49 |
GSM1296082 | X_lesional_pre-dose | 152.9 | 50 |
GSM1296115 | Y_lesional_pre-dose | 216.95 | 53 |
GSM1296084 | Z_lesional_pre-dose | 374.7 | 63 |
GSM1296072 | B_lesional_day8 | 335.99 | 61 |
GSM1296069 | L_lesional_day8 | 274.95 | 56 |
GSM1296071 | P_lesional_day8 | 222.53 | 52 |
GSM1296070 | Y_lesional_day8 | 261.67 | 56 |
GSM1296073 | V_lesional_day8 | 226.17 | 55 |
GSM1296034 | A_lesional_day15 | 385.64 | 62 |
GSM1296041 | G_lesional_day15 | 138.25 | 46 |
GSM1296035 | R_lesional_day15 | 280.6 | 58 |
GSM1296038 | U_lesional_day15 | 228.55 | 55 |
GSM1296047 | B_lesional_day15 | 305.97 | 59 |
GSM1296039 | E_lesional_day15 | 311.38 | 60 |
GSM1296042 | H_lesional_day15 | 223.41 | 53 |
GSM1296043 | L_lesional_day15 | 224.12 | 53 |
GSM1296037 | M_lesional_day15 | 278.67 | 57 |
GSM1296046 | P_lesional_day15 | 197.31 | 50 |
GSM1296044 | Q_lesional_day15 | 215.15 | 52 |
GSM1296045 | Y_lesional_day15 | 271.66 | 56 |
GSM1296025 | C_lesional_day15 | 424.57 | 65 |
GSM1296033 | D_lesional_day15 | 180.42 | 51 |
GSM1296027 | I_lesional_day15 | 266.2 | 58 |
GSM1296032 | J_lesional_day15 | 269.24 | 57 |
GSM1296024 | K_lesional_day15 | 274.38 | 58 |
GSM1296031 | W_lesional_day15 | 267.93 | 56 |
GSM1296028 | X_lesional_day15 | 218.03 | 54 |
GSM1296029 | Z_lesional_day15 | 308.1 | 59 |
GSM1296026 | F_lesional_day15 | 251.09 | 57 |
GSM1296030 | O_lesional_day15 | 242.2 | 57 |
GSM1296040 | S_lesional_day15 | 267.39 | 57 |
GSM1296036 | T_lesional_day15 | 243.99 | 55 |
GSM1296048 | V_lesional_day15 | 255.72 | 56 |
GSM1296059 | A_lesional_day43 | 197.73 | 53 |
GSM1296066 | G_lesional_day43 | 198.69 | 51 |
GSM1296060 | R_lesional_day43 | 261.81 | 56 |
GSM1296063 | U_lesional_day43 | 151.25 | 48 |
GSM1296064 | E_lesional_day43 | 279.52 | 58 |
GSM1296067 | H_lesional_day43 | 261.29 | 55 |
GSM1296062 | M_lesional_day43 | 339.66 | 61 |
GSM1296068 | Q_lesional_day43 | 210.55 | 51 |
GSM1296050 | C_lesional_day43 | 253.84 | 57 |
GSM1296057 | D_lesional_day43 | 280.46 | 58 |
GSM1296052 | I_lesional_day43 | 286.66 | 59 |
GSM1296054 | J_lesional_day43 | 382.68 | 62 |
GSM1296049 | K_lesional_day43 | 286.34 | 58 |
GSM1296055 | W_lesional_day43 | 224.56 | 53 |
GSM1296053 | X_lesional_day43 | 208.82 | 53 |
GSM1296058 | Z_lesional_day43 | 425.82 | 65 |
GSM1296051 | F_lesional_day43 | 224.13 | 55 |
GSM1296056 | O_lesional_day43 | 253.74 | 57 |
GSM1296065 | S_lesional_day43 | 255.58 | 56 |
GSM1296061 | T_lesional_day43 | 293.87 | 58 |
GSM1296095 | A_non-lesional_pre-dose | 208.08 | 53 |
GSM1296120 | B_non-lesional_pre-dose | 299.18 | 58 |
GSM1296077 | C_non-lesional_pre-dose | 315.91 | 60 |
GSM1296093 | D_non-lesional_pre-dose | 363.82 | 62 |
GSM1296104 | E_non-lesional_pre-dose | 274.16 | 58 |
GSM1296079 | F_non-lesional_pre-dose | 320.7 | 61 |
GSM1296108 | G_non-lesional_pre-dose | 212.47 | 52 |
GSM1296110 | H_non-lesional_pre-dose | 200.33 | 50 |
GSM1296081 | I_non-lesional_pre-dose | 243.62 | 56 |
GSM1296091 | J_non-lesional_pre-dose | 285.98 | 59 |
GSM1296075 | K_non-lesional_pre-dose | 237.03 | 56 |
GSM1296112 | L_non-lesional_pre-dose | 207.84 | 51 |
GSM1296100 | M_non-lesional_pre-dose | 239.55 | 55 |
GSM1296087 | O_non-lesional_pre-dose | 235.67 | 57 |
GSM1296118 | P_non-lesional_pre-dose | 250.92 | 55 |
GSM1296114 | Q_non-lesional_pre-dose | 203.11 | 51 |
GSM1296097 | R_non-lesional_pre-dose | 232.52 | 55 |
GSM1296106 | S_non-lesional_pre-dose | 274.12 | 57 |
GSM1296102 | U_non-lesional_pre-dose | 330.87 | 60 |
GSM1296122 | V_non-lesional_pre-dose | 410.8 | 64 |
GSM1296089 | W_non-lesional_pre-dose | 231 | 54 |
GSM1296083 | X_non-lesional_pre-dose | 216.43 | 53 |
GSM1296116 | Y_non-lesional_pre-dose | 245.43 | 54 |
GSM1296085 | Z_non-lesional_pre-dose | 362.33 | 62 |